Syncona: Resolution Therapeutics appoints Dr. Amol Ketkar as Chief Development Officer
London, June 30, 2022 - Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapy to treat advanced liver disease, today announced the appointment of Dr. Amol Ketkar as Chief…